Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ro vs Vaylen

Ro
Graded #38

Higher grade

vs+2.5
Vaylen
Graded #44

Lower grade

The verdict

Ro takes it — 80.2/100 to 77.7/100.

Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRo +2
68
66
Dose & formulationVaylen +2
86
88
Clinical oversightRo +2
86
84
Labs & monitoringRo +5
82
77
FulfillmentVaylen +6
84
90
Contract termsRo +25
80
55
Ro · left barVaylen · right bar

The numbers

MetricRoVaylen
WeighScore80.2/10077.7/100
GradeB−C+
Scorecard rank#38#44
SemaglutideNot disclosed$179/mo (compounded)
TirzepatideNot disclosed$239/mo (compounded)
CoverageMulti-stateAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
Ro

Graded #38 · B−

Strengths

  • Brand-name access + insurance support
  • Oral options
  • Well-funded platform

Where it loses points

  • Does not disclose compounded pricing up front
  • Premium positioning
Vaylen

Graded #44 · C+

Strengths

  • Pure GLP-1 specialist — not a multi-category telehealth platform
  • All 50 states coverage with licensed clinicians
  • Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
  • Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
  • LegitScript certified

Where it loses points

  • Compounded semaglutide at $179/mo is mid-range (not the cheapest)
  • Brand-name options at near-retail pricing ($997-$1,086/mo)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard